Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

UCB and Parkinson's UK Collaboration Improve a Trial through Patient Involvement

  • Broadcast in Science
Pharma Talk Radio

Pharma Talk Radio

×  

Follow This Show

If you liked this show, you should follow Pharma Talk Radio.
h:548881
s:11578603
archived

In this podcast, hear a case study from the 2019 Patients as Partners EU conference on UCB and Parkinson's UK Working Together to Improve a Phase 2 Trial through Patient Involvement.

In 2018, UCB and Parkinson’s UK co-developed a workshop to enable the UCB research team to work together with people affected by Parkinson’s to discuss and develop a potential phase 2 clinical trial. The aim of the workshop was to better understand people’s thoughts on clinical trials and get feedback on key features of the potential trial to maximise appropriateness, acceptability and success. In this session, attendees hear a multi-stakeholder perspective on the collaboration, including:
• How the workshop was co-developed
• Benefits and impact of patient involvement
• Key challenges and solutions during the collaboration
• Practical tips for industry and patient organisation collaborations

Speakers:
Natasha Ratcliffe, PhD, Research Involvement Manager, Parkinson’s UK
Elaine Sutcliffe, Patient Advocate
Kate Trenam, UK Patient Advocacy and Policy Manager, UCB

 

The 4th annual Patients as Partners EU conference will take place on January 27-28, 2020 in London, UK.

To learn more about patient centricity in R&D and the Patients as Partners EU program, visit theconferenceforum.org.

Facebook comments

Available when logged-in to Facebook and if Targeting Cookies are enabled